iShares Healthcare Innovation UCITS ETF (LON:HEAL)

Assets	916.98M
Expense Ratio	0.40%
PE Ratio	21.78
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	+33.66%

Volume	15,334
Open	10.22
Previous Close	10.23
Day's Range	10.16 - 10.25
52-Week Low	7.61
52-Week High	10.29
Beta	0.78
Holdings	229
Inception Date	Sep 8, 2016

About HEAL

iShares Healthcare Innovation UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. The fund is managed by BlackRock Advisors (UK) Limited. It invests in public equity markets across the globe. The fund invests in stocks of companies operating in the healthcare innovation sector. It invests in stocks of small-cap, mid-cap and large-cap companies. The fund seeks to track the performance of the iSTOXX FactSet Breakthrough Healthcare Index, by employing representative sampling methodology. iShares Healthcare Innovation UCITS ETF was formed on September 8, 2016 and is domiciled in Ireland.

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: London Stock Exchange
• Ticker Symbol: HEAL
• Provider: iShares
• Index Tracked: STOXX Global Breakthrough Healthcare Index - Benchmark TR Net

Performance

HEAL had a total return of 33.66% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.67%.

Top 10 Holdings

16.18% of assets

Name	Symbol	Weight
Moderna, Inc.	MRNA	2.20%
Guardant Health, Inc.	GH	1.70%
Natera, Inc.	NTRA	1.65%
Roivant Sciences Ltd.	ROIV	1.59%
Illumina, Inc.	ILMN	1.55%
AbbVie Inc.	ABBV	1.53%
Lonza Group AG	LONN	1.52%
Genmab A/S	GMAB	1.51%
IQVIA Holdings Inc.	IQV	1.46%
Johnson & Johnson	JNJ	1.46%

Data Sources: S&P Global Market Intelligence, Financial Modeling Prep, and more

Historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Aug 12, 2026

Data Sources Report a data error